Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Change in Inventory (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Change in Inventory for 15 consecutive years, with $8.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Inventory rose 1278.47% to $8.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $19.5 million, a 1020.73% increase, with the full-year FY2024 number at $2.1 million, up 190.01% from a year prior.
  • Change in Inventory was $8.2 million for Q3 2025 at Usana Health Sciences, up from $8.1 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $8.2 million in Q3 2025 to a low of -$8.5 million in Q3 2022.
  • A 5-year average of $562411.8 and a median of -$48000.0 in 2022 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: plummeted 126.63% in 2022, then skyrocketed 2208.97% in 2024.
  • Usana Health Sciences' Change in Inventory stood at -$1.4 million in 2021, then dropped by 11.7% to -$1.6 million in 2022, then tumbled by 32.2% to -$2.1 million in 2023, then grew by 18.52% to -$1.7 million in 2024, then soared by 586.58% to $8.2 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Change in Inventory are $8.2 million (Q3 2025), $8.1 million (Q2 2025), and $4.9 million (Q1 2025).